AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 2 - (NewsRx.com & NewsRx.net) -- A novel DNA vaccine may provide protection against methicillin-resistant Staphylococcus aureus (MRSA), researchers in Brazil report.
MRSA is "a major pathogen responsible for serious hospital infections worldwide," explained Jose P.M. Senna and colleagues at the Universidade Federal do Rio Grande do Sul and the Pontificia Universidade Catolica do Rio Grande do Sul. "These bacteria are resistant to all beta-lactam antibiotics due to the production of an additional penicillin binding protein, the PBP2a, encoded by the mecA gene, which shows low affinity for this class of antibiotics."
A vaccine based on the PBP2a protein elicited robust immune activity against MRSA in mice, Senna and coauthors found.
The researchers immunized mice with a mammalian vector expressing part of PBP2a's transpeptidase domain. Significant anti-MRSA humoral activity was seen after treatment, they said.
Study animals were challenged with sublethal doses of MRSA after immunization. The bacterial load in kidneys from vaccinated mice was 1000 times lower than the bacterial load in kidneys from control mice, according to the report.
The vaccine did not trigger ...